Home › Funds › B&D White Capital Company, LLC › ABT

B&D White Capital Company, LLC position in ABT

ABBOTT LABORATORIES · Health Care

B&D White Capital Company, LLC reported holding 242,730 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$22.0M, representing 2.19% of its reported portfolio and ranking #16 among its reported holdings. B&D White Capital Company, LLC has disclosed ABT holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)242.73K sh
Reported value held$22.03M
Portfolio Weight2.19%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How B&D White Capital Company, LLC's ABT position evolved

B&D White Capital Company, LLC first disclosed a stake in ABT in Q3 2023 at 5,800 shares (US$562K). The position peaked in Q2 2026 at 242,730 shares, worth US$22.0M. Across 3 filings, B&D White Capital Company, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 242,730 shares valued at US$22.0M — an increase of 219,230 shares quarter over quarter.. Notable position changes include a 933% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.80K $561.73K New
Q1 2026 23.50K $2.41M New
Q2 2026 242.73K $22.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has B&D White Capital Company, LLC held ABT?

B&D White Capital Company, LLC has disclosed ABT holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

What is B&D White Capital Company, LLC's current position in ABT?

As of Q2 2026, B&D White Capital Company, LLC holds 242.73K shares of ABT (ABBOTT LABORATORIES), valued at $22.03M, representing 2.19% of its reported portfolio and ranking #16.

Has B&D White Capital Company, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), B&D White Capital Company, LLC increased its position in ABT. The position peaked in Q2 2026 at 242.73K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.